Using Genomic Sequencing to Improve Management in Melanoma

Area of Science:

• Oncology
• Genomics
• Cancer Research

Background:

• Genomic sequencing technologies are rapidly advancing cancer care.
• Genomic testing plays an increasingly vital role in melanoma management.

Purpose of the Study:

• To summarize available genomic and genetic tests for melanoma.
• To evaluate the evidence supporting these tests.
• To discuss the current and future impact of genomic sequencing on melanoma management.

Main Methods:

• Review of available genomic and genetic tests for melanoma.
• Assessment of the level of evidence supporting each test.
• Discussion of the clinical impact and future roles of genomic sequencing.

Main Results:

• Multiple genomic tests are available for melanoma, including somatic tumor sequencing, tumor mutational burden, gene expression profiling, and germline genetic testing.
• The supporting data for these tests varies from robust to preliminary.
• Genomic sequencing is currently impacting melanoma management and is expected to play a larger role in the future.

Conclusions:

• Genomic testing offers diverse applications in melanoma diagnosis, prognosis, and treatment selection.
• Understanding the evidence base for each test is crucial for clinical implementation.
• Genomic sequencing is transforming melanoma care, with ongoing advancements promising further improvements.